GRI Bio, Inc. — Director's Dealing 2021

Feb 10, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vallon Pharmaceuticals, Inc. (VLON)
CIK: 0001824293
Period of Report: 2021-02-09

Reporting Person: Toren Penny (SVP, Regul Affairs & Prog Mgmt)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.84	2028-10-01	Common Stock (7813)		Direct
Stock Option (right to buy)	$3.82	2019-02-05	Common Stock (5000)		Direct

Footnotes

F1: The Stock Option vests as to one third of the underlying shares on each of October 11, 2020, October 11, 2021 and October 11, 2022.